Risk of presence of mutagenic azido impurities in sartan active…

Risk of presence of mutagenic azido impurities in sartan active…

SEMrush
29 April 2021 Strasbourg, France

Following recent investigations demonstrating the mutagenicity of an azido impurity in sartan active substances (APIs) with a tetrazole ring, the EDQM confirms that the CEP holders concerned have already been contacted and have addressed the issue as requested.

[automaticbacklinks]